Quick Answer
Health In Tech, Inc. reported R&D Expense of $1.57 million for fiscal year 2025.
Health In Tech, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.57M | -44.2% |
| 2024 | $2.81M | +40.4% |
| 2023 | $2.00M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $235.8K | -67.2% | -59.5% |
| June 30, 2025 | $582.6K | -17.0% | +8.3% |
| March 31, 2025 | $537.7K | -29.3% | -25.2% |
| September 30, 2024 | $718.4K | — | +2.4% |
| June 30, 2024 | $701.6K | — | -7.7% |
| March 31, 2024 | $760.2K | — | — |
- Health In Tech, Inc. showed a decrease of -44.2% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, Health In Tech, Inc.’s r&d expense has declined by 21.7% (from $2.00 million to $1.57 million).
- The most recent figure is from Health In Tech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: